rolapitant
Selected indexed studies
- Rolapitant. (, 2012) [PMID:31643534]
- Rolapitant. (, 2006) [PMID:39836800]
- Rolapitant: first global approval. (Drugs, 2015) [PMID:26467681]
_Worker-drafted node — pending editorial review._
Connections
rolapitant is a side effect of
Sources
- Rolapitant. (2012) pubmed
- Rolapitant. (2006) pubmed
- Rolapitant: first global approval. (2015) pubmed
- Rolapitant Is a Reversible Inhibitor of CYP2D6. (2019) pubmed
- Rolapitant treats lung cancer by targeting deubiquitinase OTUD3. (2024) pubmed
- Rolapitant: A Review in Chemotherapy-Induced Nausea and Vomiting. (2017) pubmed
- Rolapitant: a pooled analysis of its efficacy and safety in the prophylaxis of chemotherapy-induced nausea and vomiting. (2016) pubmed
- Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV). (2017) pubmed
- Rolapitant. (2016) pubmed
- Rolapitant for the treatment of chemotherapy-induced nausea and vomiting: a review of the clinical evidence. (2016) pubmed